Relationships between serum adipocyte hormones (adiponectin, leptin, resistin), bone mineral density and bone metabolic markers in osteoporosis patients.

PubWeight™: 0.97‹?› | Rank: Top 15%

🔗 View Article (PMID 24052207)

Published in J Bone Miner Metab on September 20, 2013

Authors

J Mohiti-Ardekani1, H Soleymani-Salehabadi, M B Owlia, A Mohiti

Author Affiliations

1: Department of Biochemistry and Molecular Biology, Faculty of Medicine, Shahid Saduoghi University of Medical Science, Yazd, Iran, mohiti@ssu.ac.ir.

Articles citing this

Adiponectin as a biomarker of osteoporosis in postmenopausal women: controversies. Dis Markers (2014) 0.83

Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Dis Markers (2015) 0.81

Bone-adiposity cross-talk: implications for pediatric obesity : A narrative review of literature. J Bone Miner Metab (2015) 0.79

Association of adiponectin protein and ADIPOQ gene variants with lumbar disc degeneration. Exp Ther Med (2014) 0.78

Correlation of the Lipid Profile, BMI and Bone Mineral Density in Postmenopausal Women. Mater Sociomed (2016) 0.78

Long-Term Supplementation of Green Tea Extract Does Not Modify Adiposity or Bone Mineral Density in a Randomized Trial of Overweight and Obese Postmenopausal Women. J Nutr (2015) 0.77

Lipid metabolism disorders and bone dysfunction--interrelated and mutually regulated (review). Mol Med Rep (2015) 0.77

Cytokines and Hormones That Contribute to the Positive Association between Fat and Bone. Front Endocrinol (Lausanne) (2014) 0.77

High serum adiponectin levels predict incident falls among middle-aged and older adults: a prospective cohort study. Age Ageing (2016) 0.76

Resistin promotes the abnormal Type I collagen phenotype of subchondral bone in obese patients with end stage hip osteoarthritis. Sci Rep (2017) 0.75

Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study. PLoS One (2017) 0.75

Mechanisms involved in altered bone metabolism in diabetes: a narrative review. J Diabetes Metab Disord (2016) 0.75

Evaluation of circulating sRAGE in osteoporosis according to BMI, adipokines and fracture risk: a pilot observational study. Immun Ageing (2017) 0.75

Association of Trabecular Bone Score with Inflammation and Adiposity in Patients with Psoriasis: Effect of Adalimumab Therapy. J Osteoporos (2016) 0.75

Articles cited by this

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun (1999) 14.25

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med (2001) 9.68

Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell (2000) 7.87

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest (2001) 3.64

Effects of weight and body mass index on bone mineral density in men and women: the Framingham study. J Bone Miner Res (1993) 3.31

Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes (2002) 3.04

Adiponectin as a novel determinant of bone mineral density and visceral fat. Bone (2003) 2.17

Adiponectin stimulates RANKL and inhibits OPG expression in human osteoblasts through the MAPK signaling pathway. J Bone Miner Res (2006) 2.01

Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nat Clin Pract Endocrinol Metab (2006) 1.88

Adiponectin and its receptors are expressed in bone-forming cells. Bone (2004) 1.86

Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun (2005) 1.80

Adiponectin is a negative regulator of bone mineral and bone strength in growing mice. Exp Biol Med (Maywood) (2008) 1.76

Serum adiponectin and bone mineral density in women. J Clin Endocrinol Metab (2007) 1.63

Associations between the metabolic syndrome and bone health in older men and women: the Rancho Bernardo Study. Osteoporos Int (2007) 1.61

Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem (2006) 1.46

Influence of adipokines and ghrelin on bone mineral density and fracture risk: a systematic review and meta-analysis. J Clin Endocrinol Metab (2011) 1.40

Leptin reduces ovariectomy-induced bone loss in rats. Endocrinology (2001) 1.40

In vitro and in vivo effects of adiponectin on bone. Endocrinology (2009) 1.35

Analysis of an expression profile of genes in the human adipose tissue. Gene (1997) 1.32

Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res (2004) 1.26

Adiponectin regulates bone mass via opposite central and peripheral mechanisms through FoxO1. Cell Metab (2013) 1.19

Relationship of serum leptin levels with body composition and sex steroid and insulin levels in men and women. Metabolism (2000) 1.17

Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells. BMC Cell Biol (2007) 1.10

The influence of ghrelin, adiponectin, and leptin on bone mineral density in healthy postmenopausal women. J Bone Miner Metab (2008) 1.08

The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Calcif Tissue Int (2008) 1.08

Adiponectin is associated with bone mineral density in perimenopausal women. Horm Metab Res (2005) 1.06

Relationships between serum adiponectin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in Chinese men. Clin Chim Acta (2007) 1.04

Body composition changes with age have gender-specific impacts on bone mineral density. Bone (2004) 1.04

Body weight versus body fat distribution, adiposity, and frame size as predictors of bone density. J Clin Endocrinol Metab (1995) 1.04

Influence of insulin-like growth factor-1 and leptin on bone mass in healthy postmenopausal women. Bone (2001) 0.99

Association between serum leptin concentrations and bone mineral density, and biochemical markers of bone turnover in adult men. J Clin Endocrinol Metab (2001) 0.95

Diagnostic utility of osteocalcin, undercarboxylated osteocalcin, and alkaline phosphatase for osteoporosis in premenopausal and postmenopausal women. Ann Lab Med (2011) 0.95

Serum leptin and adiponectin are positively associated with bone mineral density at the distal radius in patients with type 2 diabetes mellitus. Metabolism (2007) 0.95

Adiponectin is a predictor of bone mineral density in middle-aged premenopausal women. Osteoporos Int (2007) 0.90

Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol (2000) 0.89

Relationship of serum leptin with age, body weight, body mass index, and bone mineral density in healthy mainland Chinese women. Clin Chim Acta (2005) 0.89

The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi (2009) 0.82

Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate. Menopause (2012) 0.80

Plasma adipocytokine and ghrelin levels in relation to bone mineral density in prepubertal rhythmic gymnasts. J Bone Miner Metab (2011) 0.78

Association of circulating leptin with bone mineral density in males and females. J Med Assoc Thai (2005) 0.77

Assessment of laboratory measurements and -308 TNFalpha gene promoter polymorphisms in normal bone mineral density. Clin Rheumatol (2007) 0.75